ZA200711062B - Thiazolopyrimidines for use in therapy - Google Patents

Thiazolopyrimidines for use in therapy

Info

Publication number
ZA200711062B
ZA200711062B ZA200711062A ZA200711062A ZA200711062B ZA 200711062 B ZA200711062 B ZA 200711062B ZA 200711062 A ZA200711062 A ZA 200711062A ZA 200711062 A ZA200711062 A ZA 200711062A ZA 200711062 B ZA200711062 B ZA 200711062B
Authority
ZA
South Africa
Prior art keywords
therapy
thiazolopyrimidines
alkyl
group
nhalkyl
Prior art date
Application number
ZA200711062A
Other languages
English (en)
Inventor
Fei-Yeu Zhao
Alistair Kerr Dixon
Johnathan Mark Treherne
Chizuko Koseki
Kevin Lee
David Spanswick
Original Assignee
Sosei Co Ltd
Neurosolutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Co Ltd, Neurosolutions Ltd filed Critical Sosei Co Ltd
Publication of ZA200711062B publication Critical patent/ZA200711062B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200711062A 2005-06-20 2006-06-19 Thiazolopyrimidines for use in therapy ZA200711062B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0512554.7A GB0512554D0 (en) 2005-06-20 2005-06-20 Compounds for use in therapy

Publications (1)

Publication Number Publication Date
ZA200711062B true ZA200711062B (en) 2010-06-30

Family

ID=34855848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200711062A ZA200711062B (en) 2005-06-20 2006-06-19 Thiazolopyrimidines for use in therapy

Country Status (20)

Country Link
US (1) US8349845B2 (ko)
EP (1) EP1896031B1 (ko)
JP (1) JP5055474B2 (ko)
KR (1) KR20080076897A (ko)
CN (1) CN101355947B (ko)
AT (1) ATE419853T1 (ko)
AU (1) AU2006260714B2 (ko)
BR (1) BRPI0614386A2 (ko)
CA (1) CA2612865C (ko)
DE (1) DE602006004735D1 (ko)
DK (1) DK1896031T3 (ko)
ES (1) ES2323981T3 (ko)
GB (1) GB0512554D0 (ko)
HK (1) HK1108842A1 (ko)
IL (1) IL188061A0 (ko)
NO (1) NO20080049L (ko)
NZ (1) NZ564170A (ko)
PT (1) PT1896031E (ko)
WO (1) WO2006136806A1 (ko)
ZA (1) ZA200711062B (ko)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564591A (en) * 1978-11-10 1980-05-15 Teijin Ltd Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
JPS5566592A (en) * 1978-11-13 1980-05-20 Teijin Ltd 7-alkoxythiazolo 3,2-a pyrimidine derivative, its preparation, and drug containing the same
DE3070304D1 (en) * 1980-04-28 1985-04-25 Teijin Ltd Thiazolo(3,2-a)pyrimidine derivatives, process for preparing same, and drug containing same

Also Published As

Publication number Publication date
GB0512554D0 (en) 2005-07-27
US8349845B2 (en) 2013-01-08
BRPI0614386A2 (pt) 2011-03-22
DE602006004735D1 (de) 2009-02-26
HK1108842A1 (en) 2008-05-23
US20100216819A1 (en) 2010-08-26
AU2006260714A1 (en) 2006-12-28
WO2006136806A1 (en) 2006-12-28
CN101355947B (zh) 2013-06-05
CA2612865C (en) 2013-03-26
CA2612865A1 (en) 2006-12-28
IL188061A0 (en) 2011-08-01
JP2008543918A (ja) 2008-12-04
PT1896031E (pt) 2009-04-15
ATE419853T1 (de) 2009-01-15
NZ564170A (en) 2011-03-31
CN101355947A (zh) 2009-01-28
DK1896031T3 (da) 2009-05-11
JP5055474B2 (ja) 2012-10-24
ES2323981T3 (es) 2009-07-28
EP1896031B1 (en) 2009-01-07
KR20080076897A (ko) 2008-08-20
NO20080049L (no) 2008-01-17
EP1896031A1 (en) 2008-03-12
AU2006260714B2 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
TR201900306T4 (tr) Mek inhibitörlerini kullanma yöntemleri.
GEP20125425B (en) Biaryl ether urea compounds
MY148688A (en) 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
TW200602048A (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of β -secretase
HK1100765A1 (en) Use of rotigotine for treating and preventing parkinson's plus syndrome
BRPI0416628A (pt) uso de compostos orgánicos
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
MY151295A (en) Pyrimidyl indoline compound
HRP20090159T1 (en) Use of glucosidase inhibitors for therapy of mucovisidosis
SE0301232D0 (sv) Novel use
CY1109743T1 (el) Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
WO2005119252A3 (en) Modulators of gpr35 for the treatment of metabolic-related disorders
SG139747A1 (en) Inhibitors of the mutant form of kit
TW200612940A (en) Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament
MX2007005113A (es) Nuevos derivados de dicarboxamida.
ATE369366T1 (de) S-tenatoprazolnatrium-monohydrat-salz und dessen verwendung in form eines protonenpumpenhemmers
TW200503676A (en) Use of kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
MX2010001304A (es) Compuestos terapeuticos.
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose